Lawrence D. Stern
Chief Executive Officer at Talecris Biotherapeutics Holdings Corp.
Profile
Lawrence D.
Stern is currently the Chief Executive Officer at Talecris Biotherapeutics Holdings Corp.
and the Chairman & Chief Executive Officer at Talecris Biotherapeutics Ltd.
He is also a Member-Advisory Council at Carnegie Mellon University.
Previously, he served as the Chairman at Grifols Therapeutics, Inc. and the President at Bayer Corp.
Mr. Stern holds a graduate degree from Massachusetts Institute of Technology and an undergraduate degree from Cornell University.
Lawrence D. Stern active positions
Companies | Position | Start |
---|---|---|
Talecris Biotherapeutics Holdings Corp.
Talecris Biotherapeutics Holdings Corp. BiotechnologyHealth Technology Talecris Biotherapeutics Holdings Corp. develops and markets plasma-derived protein therapy products. The company was founded in 1942 and is headquartered in Research Triangle Park, NC. | Chief Executive Officer | 27/07/2009 |
Carnegie Mellon University
Carnegie Mellon University Other Consumer ServicesConsumer Services Carnegie Mellon University is an American school that operates as a college or university. It is located in Pittsburgh, Pennsylvania. | Director/Board Member | - |
Talecris Biotherapeutics Ltd.
Talecris Biotherapeutics Ltd. BiotechnologyHealth Technology Talecris Biotherapeutics Ltd. discovers, develops and produces critical care treatments. It is a biotherapeutic and biotechnology company that offers treatments for people with life-threatening disorders in therapeutic areas including immunology, pulmonology, and hemostasis. Talecris Biotherapeutics was founded on April 1, 2006 and is located in Mississauga, Canada. | Chief Executive Officer | 01/04/2005 |
Former positions of Lawrence D. Stern
Companies | Position | End |
---|---|---|
Grifols Therapeutics, Inc.
Grifols Therapeutics, Inc. BiotechnologyHealth Technology Grifols Therapeutics, Inc. specialized in the pharmaceutical-hospital services. The company was founded on March 7, 2005 and is headquartered in Research Triangle Park, NC. | Chairman | 14/08/2008 |
Bayer Corp.
Bayer Corp. Pharmaceuticals: MajorHealth Technology Bayer Corp. manufactures and markets pharmaceutical, healthcare, nutrition and materials products. The firm offers consumer care, diagnostics, diabetes and animal health products. It also provides material science products, which include coating, adhesive and sealant raw materials polycarbonates polyurethanes and thermoplastic polyurethane elastomers. The company was founded in 1973 and is based in Whippany, NJ. | President | - |
Training of Lawrence D. Stern
Massachusetts Institute of Technology | Graduate Degree |
Cornell University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 4 |
---|---|
Bayer Corp.
Bayer Corp. Pharmaceuticals: MajorHealth Technology Bayer Corp. manufactures and markets pharmaceutical, healthcare, nutrition and materials products. The firm offers consumer care, diagnostics, diabetes and animal health products. It also provides material science products, which include coating, adhesive and sealant raw materials polycarbonates polyurethanes and thermoplastic polyurethane elastomers. The company was founded in 1973 and is based in Whippany, NJ. | Health Technology |
Grifols Therapeutics, Inc.
Grifols Therapeutics, Inc. BiotechnologyHealth Technology Grifols Therapeutics, Inc. specialized in the pharmaceutical-hospital services. The company was founded on March 7, 2005 and is headquartered in Research Triangle Park, NC. | Health Technology |
Talecris Biotherapeutics Holdings Corp.
Talecris Biotherapeutics Holdings Corp. BiotechnologyHealth Technology Talecris Biotherapeutics Holdings Corp. develops and markets plasma-derived protein therapy products. The company was founded in 1942 and is headquartered in Research Triangle Park, NC. | Health Technology |
Talecris Biotherapeutics Ltd.
Talecris Biotherapeutics Ltd. BiotechnologyHealth Technology Talecris Biotherapeutics Ltd. discovers, develops and produces critical care treatments. It is a biotherapeutic and biotechnology company that offers treatments for people with life-threatening disorders in therapeutic areas including immunology, pulmonology, and hemostasis. Talecris Biotherapeutics was founded on April 1, 2006 and is located in Mississauga, Canada. | Health Technology |
- Stock Market
- Insiders
- Lawrence D. Stern